Clinicopathological Evaluation of Patients with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center.

South Asian J Cancer · 2025 · PMC11925626 · PMID 40124154

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly significantp = 0.06so close (0.05 < p ≤ 0.1)

We observed that patients with rMBC had a lower age (44 ± 12; 95% confidence interval [CI]: 39.2–48.8) compared with dMBC (49 ± 10; 95% CI: 46–52) at the time of metastatic presentation, which was nearly significant ( p = 0.06).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.